The Royal Victoria Hospital, colloquially known as the "Royal Vic" or "The Vic", is a hospital in Montreal, Quebec, Canada. It forms the biggest base hospital of the McGill University Health Centre, which is affiliated with McGill University.

There are 517 beds in Royal Victoria Hospital.

During the past decade, Royal Victoria Hospital conducted 73 clinical trials. In the 10-year time frame, 73 clinical trials started and 49 clinical trials were completed, i.e. on average, 67.1% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 24 clinical trials were completed. i.e. 96% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal Victoria Hospital" #1 sponsor was "McGill University Health Centre/Research Institute of the McGill University Health Centre" with 31 trials, followed by "NSABP Foundation Inc" with 15 trials sponsored, "Hoffmann-La Roche" with 12 trials sponsored, "Pfizer" with 12 trials sponsored and "Vertex Pharmaceuticals Incorporated" with 12 trials sponsored. Other sponsors include 116 different institutions and companies that sponsored additional 85 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Victoria Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 16 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 13 trials as a collaborator, "McGill University Health Centre/Research Institute of the McGill University Health Centre" with 4 trials as a collaborator, "Jewish General Hospital" with 3 trials as a collaborator and "McGill University" with 3 trials as a collaborator. Other collaborators include 111 different institutions and companies that were collaborators in the rest 105 trials.

According to Clinical.Site data, the most researched conditions in "Royal Victoria Hospital" are "Breast Cancer" (15 trials), "Cystic Fibrosis" (10 trials), "Ovarian Cancer" (8 trials), "Crohn's Disease" (6 trials) and "Multiple Myeloma" (6 trials). Many other conditions were trialed in "Royal Victoria Hospital" in a lesser frequency.

Most popular intervention types in "Royal Victoria Hospital" are "Drug" (135 trials), "Other" (34 trials), "Procedure" (18 trials), "Biological" (11 trials) and "Device" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (31 trials), "IVA" (8 trials), "cyclophosphamide" (6 trials), "Atezolizumab" (5 trials) and "Bevacizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Royal Victoria Hospital" are 154 trials for "All" genders, 40 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Royal Victoria Hospital". 1 are not yet recruiting, 19 are recruiting, 24 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 110 completed trials in Royal Victoria Hospital, undefined suspended trials, and 21 terminated clinical trials to date.

Out of the total trials that were conducted in Royal Victoria Hospital, 8 "Phase 1" clinical trials were conducted, 47 "Phase 2" clinical trials and 91 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 40 trials that are defined as “Not Applicable".